资讯

Glycomine Initiates Dosing in a Global, Randomized, Placebo-Controlled Phase 2b Study of ...

Glycomine Initiates Dosing in a Global, Randomized, Placebo-Controlled Phase 2b Study of GLM101 for the Treatment of PMM2-CDG ...

New medication lowers hard-to-control high blood pressure in people with chronic kidney disease

Adding the novel medication baxdrostat to standard care may help manage high blood pressure and delay the progression of ...

Zentalis Pharmaceuticals, Inc. (ZNTL) Presents At Morgan Stanley 23rd Annual Global ...

Explore Zentalis’ latest oncology advances and azenosertib updates for ovarian cancer from the 2025 Morgan Stanley Healthcare Conference.

Exelixis, Inc. (EXEL) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference ...

Exelixis, Inc. ( NASDAQ: EXEL) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 8:30 AM EDT ...